About Us

Hurone AI was born from a deeply personal mission to transform cancer care globally. After losing his aunt to colorectal cancer, our founder, Dr. Kingsley I. Ndoh, witnessed firsthand the devastating impact of inequities in access to timely, high-quality treatment. At the time, there were no advanced tools to bridge these gaps, and healthcare systems struggled to serve underserved populations effectively.

Hurone AI was created to change this. By leveraging adaptive AI solutions, we aim to close critical gaps in cancer care—addressing the lack of diversity in data, limited adaptability to different healthcare systems, and underrepresentation in clinical trials.

Today, our technology empowers oncologists, accelerates access to precision treatment and support, and improves patient outcomes—all while delivering measurable value for healthcare providers, payers, and industry partners. At Hurone AI, we believe that where you live should never determine whether you live or die from cancer. Discover Our Unique Approach.

Our Vision

To make AI-driven precision cancer care and support accessible to everyone, everywhere.

Our Mission

We’re working everyday to accelerate global access to precision cancer care by leveraging the transformative power of artificial intelligence. Our goal is to make health equity in cancer care a tangible reality. 

 

What Sets Us Apart

Discover how Hurone AI differentiates itself as a pioneer in precision oncology and patient navigation.

Explore Our Unique Approach

Our Team

Kingsley I. Ndoh

Founder & CEO

read bio
Max Ebong

Chief Strategy Officer 

READ BIO
Lior Romanowsky 

Chief Product Officer

READ BIO
Analise LeJeune-Stodieck

Growth and Partnerships Lead

READ BIO
Uroš Pajić

ML Engineer/Full-Stack

READ BIO
Marijana Ruiz 

Finance & Operations

READ BIO
Marko Stanojević
Marko Stanojević

Engineering Product Manager 

READ BIO
Floria Nyandaya
Floria Nyandaya

Research Fellow | Program Manager

READ BIO


BOARD ADVISORS

Nasim Eftekhari
Nasim Eftekhari, MS

Executive Director, Applied AI and Data Science, City of Hope

READ BIO
Adam Yala, PhD

Assistant Professor, Computational Precision Health UC Berkeley & UCSF

READ BIO
Irene Dankwa-Mullan, MD, MPH
Physician Executive & Former Chief Health Equity Officer, IBM Watson Health
READ BIO
Prof. Doyin Oluwole MD, FRCP, FWACP

Global Health & Management Executive

READ BIO
Susan Morgensztern 

Consultant in Emerging Health Technologies.

READ BIO
Damian
Damian Page, PhD EMBA

Senior Director at Daiichi-Sankyo in Global Oncology Medical Affairs

READ BIO
Raymond Ononiwu 

Head of Engineering at Hive Technologies, Ex-Microsoft

READ BIO
Kingsley I. Ndoh

Founder & CEO

Kingsley I. Ndoh, MD, MPH is a global health leader and visionary entrepreneur transforming oncology through AI-driven innovation. As the founder and CEO of Hurone AI, Kingsley is spearheading the next generation of cancer care—leveraging scalable technologies to cut patient costs by 50%, save oncologists 50% in follow-up time, and empower healthcare systems to thrive in value-based care models.

With deep expertise in AI policy and clinical research, Kingsley has advised the U.S. President’s Cancer Panel and forged partnerships with top cancer centers, AWS, and global institutions. Hurone AI’s groundbreaking work harnesses federated learning and diverse datasets to deliver precision oncology while safeguarding patient privacy.

Backed by a world-class team from Microsoft, MIT, and Fred Hutch, Kingsley is not just building a company—he’s redefining what’s possible in global cancer care, advancing equity and innovation for diverse populations in the U.S and around the world. He received an MD from University of Jos, MPH from University of Washington, and a Cert in Healthcare Leadership and Entrepreneurship from MIT. He holds Affiliate Faculty positions at the Fred Hutch Cancer Center and University of Washington.
Max Ebong

Chief Strategy Officer (Business Development & Marketing)

Max leads Hurone AI’s market outreach and develops innovative business models that are patient-centric and drive value to healthcare organizations and pharmaceutical companies.

His expertise in technology and healthcare has been developed through his work with Microsoft’s leading healthcare enterprise software. He has also served as Advisor in Microsoft for Startups where he guided healthcare startups in their go-to-market strategies.

Previously, he held roles at City of Hope, and Dell Technologies, where he worked at the intersection of digital innovation, business strategy, and architectural consulting. He is passionate about using technology to unlock latent value, dispel information asymmetries, and reshape the healthcare narrative.

Lior Romanowsky

Chief Product Officer

Lior began his entrepreneurial journey at the age of 16 and has since built an exceptional career driving innovation and building transformative technologies. As the founder of Spartans, a technology partner specializing in Artificial Intelligence, Augmented Reality, and Virtual Reality, Lior has spent over seven years helping global brands achieve accelerated growth through cutting-edge product innovation. Spartans has also incubated several successful B2B ventures across HRTech, MedTech, and TravelTech, demonstrating Lior’s talent for scaling digital solutions.

Among his ventures is Jenna AI, an AI-driven solution for candidate screening and matchmaking, which is transforming hiring processes for businesses. Lior’s expertise in leveraging emerging technologies has solidified his reputation as a thought leader in product development and growth acceleration.

In his role as Chief Product Officer at Hurone AI, Lior drives the technological vision and product strategy, ensuring the platform meets the highest standards of innovation and scalability. His passion for building impactful solutions aligns seamlessly with Hurone AI’s mission to transform global cancer care through responsible AI. Lior’s proven track record of success and visionary leadership make him an invaluable member of the team.
Analise LeJeune-Stodieck
Hurone AI’s Growth and Partnerships Lead
Analise LeJeune-Stodieck serves as Hurone AI’s Growth and Partnerships Lead, leveraging her deep expertise in building strategic collaborations to advance the company’s commercial and R&D partnerships. She brings years of experience working at the intersection of global health, innovation, and impact, with a proven track record of aligning stakeholders across sectors to deliver sustainable solutions.

Analise has previously worked with organizations like BIO Ventures for Global Health, where she assessed cancer care capacity in Nigeria and collaborated with government and hospital leaders to expand access to affordable cancer therapeutics. She has also been deeply engaged with leading pharmaceutical companies and some of the world’s largest philanthropic organizations, driving initiatives to strengthen diagnostic services, accelerate drug and vaccine R&D on behalf of Panorama, and improve health outcomes in underserved regions.

Her commitment to global health innovation aligns seamlessly with Hurone AI’s mission to democratize precision cancer care. Analise holds a Bachelor of Arts in Public Health from the University of Washington and is based in the Pacific Northwest, where she enjoys skiing, backpacking, and surfing when she’s not focused on advancing Hurone AI’s impact.
Uroš Pajić

Machine Learning Engineer/Full-Stack Software Developer

Uroš is specialized in deploying generative AI techniques, especially leveraging LLMs. At Hurone AI, he has channeled his expertise into pioneering transformative AI-driven solutions and integrating culturally sensitive models into Hurone’s platform.

Uroš has led projects to integrate machine learning models for video similarity classifications and innovatively employ algorithms for video enhancements. He has worked in building AI tools for Caladria Technologies and the United Nations Development Programme.

Marijana Ruiz

Finance & Operations

Marijana is a Grant and Investment Capital Consultant, Senior Finance and Operations Executive with over 25 years’ extensive experience in biotechnology and global health.

She has managed cumulatively over $100M as Director of Finance Global Oncology, at Fred Hutch, and Director of Finance for Infectious Disease Research Institute (now Access to Advanced Health Institute).

She holds an MBA from the Washington State University’s Carson College of Business and a BSc in Finance & International Business from the University of Washington.

Marko Stanojević

Engineering Product Manager, Hurone AI

Marko is the Engineering Product Manager at Hurone AI. He has a Bachelor of Science in Computer Science from the Belgrade Institute of Technology. His expertise in software engineering and product development plays a key role in Hurone AI’s success.

Marko’s ability to bridge technology and user experience has been vital in driving the launch of Hurone AI’s innovative products. His collaborative approach and adaptability ensure that the company’s solutions meet the highest standards.

Outside of work, Marko is passionate about technology and stays updated on the latest industry trends. His commitment to continuous learning makes him an invaluable asset to the Hurone AI team.

Floria Nyandaya

Research Fellow | Program Manager, Hurone AI

Floria Nyandaya is a physician-scientist dedicated to tackling health disparities in non-communicable diseases(NCDs) amidst Africa’s epidemiological transition. 

With a diverse background in primary clinical practice, healthcare management, infectious disease surveillance and NCD research, she has recently expanded her focus to digital health technologies. As a recipient of the Cardiometabolic Research Fellowship and the Thomas Francis Jr. Global Health Fellowship in her MPH program, Floria gained hands-on global health experience in the U.S., Nigeria, and Kenya. 

Her research endeavors have been multifaceted, from advancing women’s cardiovascular health to exploring the utility of artificial intelligence in enhancing renal and cancer care and addressing diversity gaps in clinical trial research. Continuously driven by her passion for making a tangible difference, Floria remains dedicated to improving the health and well-being of underserved populations.

 
Nasim Eftekhari, MS

Executive Director of Applied AI and Data Science, City of Hope

Nasim leads the applied AI and data science department at City of Hope, one of the largest cancer research and treatment organizations in the United States.

She supervises teams that are responsible for applying machine learning to support clinical decision support and patient care, research, and precision medicine, as well as operations and finance. Before joining City of Hope in 2017, Nasim co-founded an AI company focusing on social media data mining and financial markets and political events prediction. She continues to advise startup companies, including Hurone AI, on successful implementation of AI solutions.

Adam Yala, PhD

Assistant Professor, Computational Precision Health UC Berkeley & UCSF

Adam is an Assistant Professor of Computational Precision Medicine at UC Berkeley & UCSF. His interest lies in the intersection of machine learning and precision medicine. He believes that algorithmic innovation can create more precise and equitable healthcare.

His previous work has contributed to three areas:

1. Predicting future cancer risk,
2. Designing personalized screening policies and
3. Private data sharing through neural obfuscation.

His tools have been implemented at multiple hospital systems around the world and underlie prospective clinical trials.

Dr. Irene Dankwa-Mullan, MD, MPH

Physician Executive & Former Chief Health Equity Officer, IBM Watson Health

Dr. Irene Dankwa-Mullan is an industry physician, consultant, scientist, thought leader, health equity scholar with over 20 years of diverse regional and national leadership experience in primary care, healthcare systems, research, and the community. She served as the Chief Health Equity Officer and Deputy Chief Health Officer at Merative, formerly IBM Watson Health.

She was a member of the IBM Industry Academy, a selected community of pre-eminent leaders to drive innovation and engage in cutting-edge work for the industry. She previously served as Deputy Director for extramural scientific programs at NIMHD, NIH. While at the NIH, she was active on several key strategic committees, including many that were cross-sectoral promoting health equity and health in all policies.

She serves on various advisory boards and mentors in STEM. Irene has published widely on health equity, applied artificial intelligence (AI) and machine-learning, including ethical and responsible AI for social good.

Prof. Doyin Oluwole MD, FRCP, FWACP

Global Health & Management Executive – Women’s/Maternal, Newborn & Child Health

Prof. Doyin Oluwole is a Global Health executive. She has led a wide range of innovative global health programs in Africa and Latin America.

Between 2012 and 2015, she was the founding Executive Director of Pink Ribbon Red Ribbon (PRRR) now “Go Further” the global public-private partnership on cervical cancer and breast cancer at the George W. Bush Institute—where she guided strategy, targets and timeline and represented partners’ collective interests with governmental, public and private partners.

Oluwole has spent 40 plus years as a clinical, academic and global public health practitioner across Africa and the United States, including 10 years with executive management responsibility at the regional level and as a country World Health Organization (WHO) representative; and five at chief executive officer level in the United States.

Susan Morgensztern

Consultant in Emerging Health Technologies

Susan is a biotech leader with over 35 years of experience as a strategic development consultant for new technologies and markets to biotechnology, medical device and diagnostic firms.

She serves on the Advisory Board of the UW School of Public Health and the University of Massachusetts Institute for Diversity Sciences. Previously co-chaired Technology Screening Committee of WINGS Angel Network, Board Chair of Seattle BioMed, and Expert Reviewer for the Life Science Discovery Fund.

Damian Page, PhD EMBA
Senior Director at Daiichi-Sankyo in Global Oncology Medical Affairs
For his entire professional career in the Pharma and MedTech Industry, Damian has been passionate about improving outcomes for people with cancer by making data-enabled precision oncology a clinical reality.

He currently serves as a Senior Director at Daiichi-Sankyo in Global Oncology Medical Affairs and focuses with his team to advance treatment paradigms for patients around the world with a new type of targeted therapies known as Antibody-Drug-Conjugates (ADCs).

Prior to Daiichi-Sankyo, Damian has been working for Roche for more than 15 years where he held various senior medical and commercial operations positions to advance precision oncology at the interface of data, diagnostics and therapeutic intervention.

Damian also serves on the strategic advisory board of AI-Medical AG, a Swiss start-up that develops intuitive, powerful, and easy-to-use diagnostic software solutions adapted for neuroradiologists and radiation-oncologists to set a new standard in the quality and the quantification of neuroradiological reporting.
Raymond Ononiwu

Head of Engineering at Hive Technologies, Ex-Microsoft

Raymond is a cloud expert and a Microsoft veteran with a decade of experience in the tech sector. He is an industry leader with a wealth of knowledge about cloud computing and cloud solutions.